Role of Transient Receptor Potential Vanilloid 4 (TRPV4) in cardiac autophagy and ischemia-reperfusion
Description: The leading cause of heart disease deaths in the United States in aged individuals is coronary artery disease (CAD). Sequela of CAD includes myocardial infarction and sudden cardiac arrest which often results from cardiac remodeling secondary to ischemia-reperfusion (I/R) injury. Cellular autophagy is vital to the cardiomyocyte as it allows the cell to scavenge bulk cytoplasm for energy production under times of stress. Dysregulated autophagy is associated with myocardial injury in the reperfusion phase after heart attacks. Expression of the Transient Receptor Potential Vanilloid 4 (TRPV4) ion channel increases in cardiomyocytes with aging and has been associated with cardiomyocyte dysfunction after I/R. TRPV4 channels have been implicated in autophagy yet no studies have identified a direct role of TRPV4 in cardiomyocyte autophagy. My novel preliminary data indicate that inhibition of TRPV4 stimulates autophagy in cardiomyocytes of Aged mice, and this unique phenotype is absent in myocytes of Young mice. Thus, the goal of this Fellowship proposal is to better understand the role of TRPV4 in cardiomyocyte autophagy and identify if TRPV4 inhibition is a rational therapeutic approach to prevent cardiac dysfunction after I/R injury. The central hypothesis is that increased activity of TRPV4 in the aged myocardium limits cardiac autophagy with aging and I/R injury. Specific Aim 1 will use advanced imaging techniques and Western Blotting in isolated cardiomyocytes of Young and Aged mice with genetic (TRPV4 overexpression or deletion) and pharmacological (TRPV4 agonists and antagonists) manipulation of TRPV4 activity to test the hypothesis that TRPV4 mediated calcium release from intracellular calcium stores inhibits autophagy via CaMKII inhibitory phosphorylation of Beclin1. Specific Aim 2 will use genetic and pharmacologic approaches in Aged mice subjected to in vivo I/R injury to test the hypothesis that TRPV4 inhibition will stimulate autophagy following I/R injury and prevent cardiac dysfunction. In whole, this project will elucidate the role of TRPV4 in cardiac autophagy with aging and I/R and provide the applicant with the opportunity to learn new skills, develop critical scientific thinking, and continue to further a career as a physician scientist.
Funder: American Heart Association
Amount: $69,550
Funding type: training
Funder scheme: Predoctoral Fellowship
Start date: 2025-01-01
End date: 2026-12-31
Investigator: Matthew Hayden (lead)
Institutions: University of Missouri, The Curators of the University of Missouri (Columbia)
Topic: Ion Channels and Receptors
Subfield: Sensory Systems
Field: Neuroscience
Domain: Life Sciences
Funded outputs count: 1
Funder award ID: 25PRE1377074
OpenAlex ID: G1778775133
